Targeting HIV Retention and Improved Viral Load Through Engagement ('THRIVE')
Part of paid clinical trials in Houston, Texas.
- Sponsor
- Baylor College of Medicine
- Study ID
- NCT04481373
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- THRIVE — BEHAVIORALThe ACT components (3-3.5 hours) will focus on clarifying patient values and goals and identifying obstacles that may be getting in the way of living a rich life. Short-and long-term effects of avoidance will be discussed (e.g., avoidance reduces immediate contact with distressing experiences and provides short-term relief but leads to greater dysfunction in long run). Patients will be taught acceptance, mindfulness, and perspective taking to help patient cope with difficult emotions and thoughts that may interfere with living a values-driven life. Individuals will also be encouraged to examine the costs of stigmatization on their life (e.g. avoidance of medical care, sense of isolation). Education will include medical information about HIV, services available at the clinic, and health needs related to comorbidities. This content to be delivered in 30 minutes.
- Treatment as Usual — OTHERPatients get usual care at the hospital. Service linkage workers (SLWs) meet with all hospitalized PWH and cover educational aspects of the care.
Study Details
Many people with HIV infection are not consistently engaged in outpatient HIV care, and avoidance, stigma and denial contribute to poor engagement in HIV care. This project will develop and pilot test a new intervention, "THRIVE," for hospitalized persons who are out of HIV care and endorse avoidance, to improve how well they stay in outpatient HIV care after discharge. If successfully developed, the intervention will undergo large scale testing in later studies and could improve the health of persons with HIV infection and help end the HIV epidemic in the United States.
Key Dates
- Start date
- Mar 3, 2021
- Status verified
- Sep 2025
- Primary completion
- Feb 29, 2024
- Completion
- Feb 29, 2024
Study Design
- Enrollment
- 75 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: THRIVEAcceptance and Commitment Therapy plus Education about HIV A master's level mental health professional will provide the 4-5 hour intervention for out-of-care PWH during a hospitalization. There are two important components to the intervention: Acceptance and Commitment Therapy (ACT) content, targeting avoidance with acceptance-based coping and active engagement in values-based living, and HIV education.
- Other: Treatment as UsualPatients get usual care at the hospital. Service linkage workers (SLWs) meet with all hospitalized PWH and cover educational aspects of the care.
Primary Outcome Measure
Acceptability of Enrollment and Randomization: Eligible But Declined Participation [ Time Frame: 6 months ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ben Taub Hospital | Houston | Texas | 77030 | - |
Find similar trials in Houston, TX
By condition
By research site
Related Studies
- Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC VirusPHASE2 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas
- Dallas 2K: A Natural History Study of DepressionRecruiting · University of Texas Southwestern Medical Center · Dallas, Texas
- Youth Depression and Suicide Research NetworkEnrolling By Invitation · University of Texas Southwestern Medical Center · Dallas, Texas
- A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.PHASE3 · Recruiting · AbbVie · Bentonville, Arkansas